Integrated Filing — IndAS



General information about company
Scrip Code 544339
NSE Symbol LAXMIDENTL
MSEI Symbol NOTLISTED
ISIN INE0WO601020
Name of company Laxmi Dental Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 26-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 21-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 26-May-2025   17:00:00
End date and time of board meeting 26-May-2025   23:55:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 606680000 2391070000
Other income 16310000 33380000
Total income 622990000 2424450000
2 Expenses
(a) Cost of materials consumed 41050000 372270000
(b) Purchases of stock-in-trade 92520000 194590000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -4650000 5550000
(d) Employee benefit expense 244070000 857680000
(e) Finance costs 12570000 53900000
(f) Depreciation, depletion and amortisation expense 42980000 150190000
(f) Other Expenses
1 Other Expenses 138450000 542250000
Total other expenses 138450000 542250000
Total expenses 566990000 2176430000
3 Total profit before exceptional items and tax 56000000 248020000
4 Exceptional items 4100000 70270000
5 Total profit before tax 60100000 318290000
6 Tax expense
7 Current tax 9130000 22210000
8 Deferred tax 15650000 42330000
9 Total tax expenses 24780000 64540000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 35320000 253750000
12 Profit (loss) from discontinued operations before tax 0 -8090000
13 Tax expense of discontinued operations 0 -1000000
14 Net profit (loss) from discontinued operation after tax 0 -7090000
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 7430000 71680000
16 Total profit (loss) for period 42750000 318340000
17 Other comprehensive income net of taxes -5610000 -5340000
18 Total Comprehensive Income for the period 37140000 313000000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 42820000 317710000
Total profit or loss, attributable to non-controlling interests -70000 630000
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 37190000 312340000
Total comprehensive income for the period attributable to owners of parent non-controlling interests -50000 660000
21 Details of equity share capital
Paid-up equity share capital 109920000 109920000
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve 1975450000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.79 6.2
Diluted earnings (loss) per share from continuing operations 0.78 6.19
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 -0.14
Diluted earnings (loss) per share from discontinued operations 0 -0.14
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.79 6.06
Diluted earnings (loss) per share from continuing and discontinued operations 0.78 6.05
24 Debt equity ratio 0.0005 0.0005
25 Debt service coverage ratio 0.0104 0.0104
26 Interest service coverage ratio 0.0758 0.0777
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results
Textual Information(1) Note to the Consolidated Financial Results: n n1 The audited consolidated financial results for the year ended 31 March 2025 has been prepared on the basis of the consolidated annual financial statements in accordance with Indian Accounting Standards as notified under the Companies Indian Accounting Standards Rules 2015 as amended specified under section 133 of the Companies Act, 2013 and in compliance with Regulation 33 of the SEBI Listing Obligations and Disclosure Requirements Regulations 2015 the Regulation as amended were reviewed and recommended by the Audit Committee and approved by the Board of Directors at their respective meeting held on 26 May n2025. The Statutory Auditors of the Company have expressed an unmodified opinion on the audited consolidated financial results for the year ended 31 March 2025. n n2 The figures of the quarter ended 31 March 2025 are the balancing figures between the audited figures in respect of full financial year and the unaudited published year to date figures upto 31 December 2024 which were subject to limited review. n n3 The figures of the quarter ended 31 March 2024 are the balancing figures between the audited figures in respect of full financial year General purpose consolidated financial statements of the group and the year to date figures upto 31 December 2023 based on the information compiled by the management in accordance with Ind AS and have not been subjected to review or audit by the statutory auditor or by any other auditor. n nConsolidated Segment wise Revenue Results Assets and Liabilities. n nThe Chief Operational Decision Maker CODM monitors the operating results of its Business Segments separately for the purpose of making decisions about resource allocation and performance assessment. Segment performance is evaluated based on profit or loss and is measured consistently with profit or loss in the consolidated financial statements. Operating segments have been identified on the basis of the nature of products / services and have been identified as per the quantitative criteria specified in the Ind AS 108 which are described below n nLaboratory Business This segment comprises of Dental Prosthesis such as metal free crowns and bridges Porcelain Fused to Metal PFM Crowns and Bridges Dentures. n nAligners Business This segment comprises of Dental Aligners Retainers Raw Materials for Aligners Sport Guards Night Guards Sleep Apnea Devices. n nOther Business This segment comprises of Dental distribution products used in Dental Laboratory Dental Clinical Services and Dental Educational Courses. n nSegment assets and liabilities The CODM does not monitor operating assets used by the operating segment. Therefore disclosures of segment assets liabilities and capital expenditure have not been given. n n5 During the year ended 31 March 2025 the Company has converted the 0.0001% Compulsorily Convertible Preference Shares CCPS aggregating to 290597 preference shares of par value of Rs 400 each to 23922450 Equity Shares of Rs 2 each. n n6 During the year the Board of Directors and Shareholders of the Company has approved the Employee Stock Option Plan 2024 ESOP 2024 for the employees of the Company and its subsidiary companies comprising of equity shares of the Company not exceeding 500000 equity shares of face value of Rs. 2 each. The company has granted 351672 equity shares of face value of Rs 2 each on 14 December 2024 to its eligible employees. n n7 On 7 May 2024 the Holding Company sold one of its Investment properties at the sale consideration of Rs 101 million. The book value of the aforesaid Property as on the date of sale was Rs. 7.10 million. The Holding Company accounted for difference between the sale consideration and book value as gain on sale of Investment property amounting to Rs. 70.27 million net of tax Rs 23.64 million as an exceptional gain. Subsequent to the quarter and six month period ended 30 September 2024 the Holding Company has opted to avail benefit of section 115BAA and the corresponding revision of net tax effect has been considered in the exception items. n nDuring the year ended 31 March 2025 the Company split its 309060 equity shares of face value of Rs.10 each to 1545300 Equity Shares of face value of Rs 2 each. nFurther on approval of the Board of Directors and Shareholders the company issued 26270100 bonus shares 17:1 face value of Rs 2 each by capitalizing the free reserves. Basic and Diluted EPS disclosed after considering effect of bonus and split equity shares issued. n n9 During the quarter and year ended 31 March 2025 the Company has completed an Initial Public Offer of 16309766 equity shares of face value of Rs. 2 each comprising of fresh issue of 3224299 equity shares at an issue price of Rs 428 per equity share aggregating to Rs. 1380 million and an offer for sale of 13085467 equity shares at an issue price of Rs 428 per equity share aggregating to Rs. 5600.58 million and listed on both Bombay Stock Exchange Limited BSE and National Stock Exchange NSE on 20 January 2025. The Company has received gross proceeds from fresh issue of Rs 1380.00 million against which Company has incurred an estimated issue related expenses net off tax of Rs 92.29 million. Out of the net proceeds which were unutilised as at 31 March 2025 Rs 950.33 million are temporarily invested in fixed deposits. n nOn 16 August 2024 the Group entered into a Contract for Sale of division i.e. Alvy Dental Supply considering the carrying value as at 30 June 2024. The Group de- recognized the net carrying value of assets other than cash and cash equivalent of INR 17.76 millions as on date of sale i.e.30 June 2024 on completion of closure terms. During the year ended 31 March 2025 the said division has been sold out at the value at which the same was recognised. n n11 Previous year period figures have been regrouped reclassified whenever necessary to confirm to current years classification. n n12 The financial results of the Company are available on the Companys website www.laxmidentallimited.com and stock exchanges websites BSE www.bseindia.com and NSE www.nseindia.com where the shares of the Company are listed. n n n



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 411260000
Capital work-in-progress
Investment property 0
Goodwill 0
Other intangible assets 94080000
Intangible assets under development 2150000
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 103840000
Trade receivables, non-current
Loans, non-current 0
Other non-current financial assets 264070000
Total non-current financial assets 367910000
Deferred tax assets (net) 100690000
Other non-current assets
Total non-current assets 976090000
2 Current assets
Inventories 186500000
Current financial asset
Current investments 0
Trade receivables, current 366760000
Cash and cash equivalents 908180000
Bank balance other than cash and cash equivalents 185420000
Loans, current 1720000
Other current financial assets 61110000
Total current financial assets 1523190000
Current tax assets (net)
Other current assets 160870000
Total current assets 1870560000
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 2846650000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 109920000
Other equity 1975450000
Total equity attributable to owners of parent 2085370000
Non controlling interest 1640000
Total equity 2087010000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 106090000
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities 5400000
Total non-current financial liabilities 111490000
Provisions, non-current 34590000
Deferred tax liabilities (net)
Deferred government grants, Non-current
Other non-current liabilities 46520000
Total non-current liabilities 192600000
Current liabilities
Current financial liabilities
Borrowings, current 7580000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 15310000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 305290000
Total Trade payable 320600000
Other current financial liabilities 70420000
Total current financial liabilities 398600000
Other current liabilities 145690000
Provisions, current 12000000
Current tax liabilities (Net) 10750000
Deferred government grants, Current
Total current liabilities 567040000
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 759640000
Total equity and liabilites 2846650000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Laboratory Business 384440000 1541620000
2 Aligners Business 192180000 808510000
3 Other Business 47370000 149450000
Total Segment Revenue 623990000 2499580000
Less: Inter segment revenue 17310000 17310000
Revenue from operations 606680000 2391070000
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Laboratory Business 83270000 262220000
2 Aligners Business 14350000 149200000
3 Other Business -2360000 7310000
Total Profit before tax 95260000 418730000
i. Finance cost 12570000 12570000
ii. Other Unallocable Expenditure net off Unallocable income 26660000 26660000
Profit before tax 56030000 248030000
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Laboratory Business 0 0
2 Aligners Business 0 0
3 Other Business 0 0
Total Segment Asset 0 0
Un-allocable Assets 0 0
Net Segment Asset 0 0
4 Segment Liabilities
Segment Liabilities
1 Laboratory Business 0 0
2 Aligners Business 0 0
3 Other Business 0 0
Total Segment Liabilities 0 0
Un-allocable Liabilities 0 0
Net Segment Liabilities 0 0
Disclosure of notes on segments Textual Information(2)



Text Block
Textual Information(2) Segment assets and liabilities n nThe Chief Opcmtional Decision Maker does not monitor operating assets used by the operating segment. Therefore, disclosures of segment assets, liabilities and capital expenditure have not been given.



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement gain of net defined benefit plan -7300000 -7600000
2 lncome tax effect on above 1670000 1900000
Total Amount of items that will not be reclassified to profit and loss -5630000 -5700000
2 Income tax relating to items that will not be reclassified to profit or loss 0 0
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss -20000 -360000
5 Total Other comprehensive income -5610000 -5340000



Cash flow statement, indirect
Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Consolidated
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 318290000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 53900000
Adjustments for decrease (increase) in inventories 77450000
Adjustments for decrease (increase) in trade receivables, current -103740000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets 0
Adjustments for decrease (increase) in other non-current assets -42370000
Adjustments for other financial assets, non-current -42660000
Adjustments for other financial assets, current 0
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current 123140000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 0
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 150190000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 5850000
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current 0
Adjustments for other financial liabilities, non-current 6960000
Adjustments for unrealised foreign exchange losses gains -15200000
Adjustments for dividend income 0
Adjustments for interest income 14320000
Adjustments for share-based payments 21900000
Adjustments for fair value losses (gains) -70270000
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 2230000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships -8090000
Total adjustments for reconcile profit (loss) 144970000
Net cash flows from (used in) operations 463260000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 24940000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities 438320000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 2100000
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 76360000
Purchase of property, plant and equipment 151240000
Proceeds from sales of investment property 7540000
Purchase of investment property 15010000
Proceeds from sales of intangible assets 0
Purchase of intangible assets 9540000
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 14320000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -216950000
Net cash flows from (used in) investing activities -292420000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 1380000000
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 38660000
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 203850000
Repayments of borrowings 337970000
Payments of lease liabilities 46900000
Dividends paid 0
Interest paid 53900000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities 1106420000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 1252320000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 360000
Net increase (decrease) in cash and cash equivalents 1252680000
Cash and cash equivalents cash flow statement at beginning of period -159080000
Cash and cash equivalents cash flow statement at end of period 1093600000





Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 M S K A & Associates Yes 31-Jul-2027